These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
120 related items for PubMed ID: 21397254
1. 1 H-MR spectroscopy in ultra-high risk and first episode stages of schizophrenia. Uhl I, Mavrogiorgou P, Norra C, Forstreuter F, Scheel M, Witthaus H, Ozgürdal S, Gudlowski Y, Bohner G, Gallinat J, Klingebiel R, Heinz A, Juckel G. J Psychiatr Res; 2011 Sep; 45(9):1135-9. PubMed ID: 21397254 [Abstract] [Full Text] [Related]
2. Hippocampal neurochemical pathology in patients at first episode of affective psychosis: a proton magnetic resonance spectroscopic imaging study. Blasi G, Bertolino A, Brudaglio F, Sciota D, Altamura M, Antonucci N, Scarabino T, Weinberger DR, Nardini M. Psychiatry Res; 2004 Jul 30; 131(2):95-105. PubMed ID: 15313516 [Abstract] [Full Text] [Related]
3. Duration of untreated psychosis vs. N-acetylaspartate and choline in first episode schizophrenia: a 1H magnetic resonance spectroscopy study at 4.0 Tesla. Théberge J, Al-Semaan Y, Drost DJ, Malla AK, Neufeld RW, Bartha R, Manchanda R, Menon R, Densmore M, Schaefer B, Williamson PC. Psychiatry Res; 2004 Jul 30; 131(2):107-14. PubMed ID: 15313517 [Abstract] [Full Text] [Related]
4. Prediction of functional outcome 18 months after a first psychotic episode: a proton magnetic resonance spectroscopy study. Wood SJ, Berger GE, Lambert M, Conus P, Velakoulis D, Stuart GW, Desmond P, McGorry PD, Pantelis C. Arch Gen Psychiatry; 2006 Sep 30; 63(9):969-76. PubMed ID: 16952999 [Abstract] [Full Text] [Related]
5. Proton magnetic resonance spectroscopy in subjects with high genetic risk of schizophrenia: investigation of anterior cingulate, dorsolateral prefrontal cortex and thalamus. Yoo SY, Yeon S, Choi CH, Kang DH, Lee JM, Shin NY, Jung WH, Choi JS, Jang DP, Kwon JS. Schizophr Res; 2009 Jun 30; 111(1-3):86-93. PubMed ID: 19406622 [Abstract] [Full Text] [Related]
6. 1H MRSI evidence of metabolic abnormalities in childhood-onset schizophrenia. O'Neill J, Levitt J, Caplan R, Asarnow R, McCracken JT, Toga AW, Alger JR. Neuroimage; 2004 Apr 30; 21(4):1781-9. PubMed ID: 15050598 [Abstract] [Full Text] [Related]
7. Cognitive impairment and in vivo metabolites in first-episode neuroleptic-naive and chronic medicated schizophrenic patients: a proton magnetic resonance spectroscopy study. Ohrmann P, Siegmund A, Suslow T, Pedersen A, Spitzberg K, Kersting A, Rothermundt M, Arolt V, Heindel W, Pfleiderer B. J Psychiatr Res; 2007 Oct 30; 41(8):625-34. PubMed ID: 16949099 [Abstract] [Full Text] [Related]
8. Altered metabolic integrity of corpus callosum among individuals at ultra high risk of schizophrenia and first-episode patients. Aydin K, Ucok A, Guler J. Biol Psychiatry; 2008 Nov 01; 64(9):750-7. PubMed ID: 18486106 [Abstract] [Full Text] [Related]
9. Metabolite changes and gender differences in schizophrenia using 3-Tesla proton magnetic resonance spectroscopy (1H-MRS). Tayoshi S, Sumitani S, Taniguchi K, Shibuya-Tayoshi S, Numata S, Iga J, Nakataki M, Ueno S, Harada M, Ohmori T. Schizophr Res; 2009 Mar 01; 108(1-3):69-77. PubMed ID: 19097753 [Abstract] [Full Text] [Related]
10. Proton magnetic resonance spectroscopy in first episode psychosis and ultra high-risk individuals. Wood SJ, Berger G, Velakoulis D, Phillips LJ, McGorry PD, Yung AR, Desmond P, Pantelis C. Schizophr Bull; 2003 Mar 01; 29(4):831-43. PubMed ID: 14989417 [Abstract] [Full Text] [Related]
11. Quantitative magnetic resonance spectroscopy of schizophrenia: relationship between decreased N-acetylaspartate and frontal lobe dysfunction. Tanaka Y, Obata T, Sassa T, Yoshitome E, Asai Y, Ikehira H, Suhara T, Okubo Y, Nishikawa T. Psychiatry Clin Neurosci; 2006 Jun 01; 60(3):365-72. PubMed ID: 16732755 [Abstract] [Full Text] [Related]
12. Proton magnetic resonance spectroscopy detects a relative decrease of N-acetylaspartate in the hippocampus of patients with dementia with Lewy bodies. Xuan X, Ding M, Gong X. J Neuroimaging; 2008 Apr 01; 18(2):137-41. PubMed ID: 18333837 [Abstract] [Full Text] [Related]
13. [Proton magnetic resonance spectroscopic imaging of the hippocampus in schizophrenia patients before and after surgery]. Chang HM, Qi ST, Yang KJ, Wang KW, Guo ZW, Wang H. Nan Fang Yi Ke Da Xue Xue Bao; 2009 May 01; 29(5):996-8. PubMed ID: 19460730 [Abstract] [Full Text] [Related]
14. [Estimation of postmortem interval with multivoxel-voxel proton 1H-MR spectroscopy]. Yang TT, Li ZW, Liu L, Zheng N. Fa Yi Xue Za Zhi; 2007 Dec 01; 23(6):405-8. PubMed ID: 18402106 [Abstract] [Full Text] [Related]
16. MRI volumetry and proton MR spectroscopy of the brain in Lafora disease. Villanueva V, Alvarez-Linera J, Gómez-Garre P, Gutiérrez J, Serratosa JM. Epilepsia; 2006 Apr 01; 47(4):788-92. PubMed ID: 16650146 [Abstract] [Full Text] [Related]
17. (1)H magnetic resonance spectroscopy imaging of the hippocampus in patients with panic disorder. Trzesniak C, Uchida RR, Araújo D, Guimarães FS, Freitas-Ferrari MC, Filho AS, Santos AC, Busatto GF, Zuardi AW, Del-Ben CM, Graeff FG, Crippa JA. Psychiatry Res; 2010 Jun 30; 182(3):261-5. PubMed ID: 20488674 [Abstract] [Full Text] [Related]
18. Atypical antipsychotic drug treatment for 6 months restores N-acetylaspartate in left prefrontal cortex and left thalamus of first-episode patients with early onset schizophrenia: A magnetic resonance spectroscopy study. Gan JL, Cheng ZX, Duan HF, Yang JM, Zhu XQ, Gao CY. Psychiatry Res; 2014 Jul 30; 223(1):23-7. PubMed ID: 24831926 [Abstract] [Full Text] [Related]
19. Methamphetamine users in sustained abstinence: a proton magnetic resonance spectroscopy study. Nordahl TE, Salo R, Natsuaki Y, Galloway GP, Waters C, Moore CD, Kile S, Buonocore MH. Arch Gen Psychiatry; 2005 Apr 30; 62(4):444-52. PubMed ID: 15809412 [Abstract] [Full Text] [Related]
20. Proton magnetic resonance spectroscopy in school-aged autistic children. Vasconcelos MM, Brito AR, Domingues RC, da Cruz LC, Gasparetto EL, Werner J, Gonçalves JP. J Neuroimaging; 2008 Jul 30; 18(3):288-95. PubMed ID: 18304036 [Abstract] [Full Text] [Related] Page: [Next] [New Search]